Standigm

5th Floor, 56, Nonhyeon-ro 67-gil
Gangnam-gu
Seoul
06250
South Korea

Show jobs for this employer

About Standigm

Standigm is a company to apply cutting-edge AI technologies to drug discovery and development. Standigm focuses on predicting new indications for existing drugs, called drug repositioning through the deeply trained AI model with molecular features of drug responses and drug uses. Standigm generated tens of drug candidates for cancers, Parkinson's disease (PD), autism, fatty liver diseases (NASH) and more. Standigm was found in May 2015 by cofounders from Samsung Advanced Institute of Technology. Standigm has raised $3.4M.

YEAR FOUNDED:

May 2015

LEADERSHIP:

Founders: Jinhan Kim, Sang Ok Song, and So Jeong Yun

Founder and CEO: Jinhan Kim

Founder and COO: Sang Ok Song

Founder and CRO: So Jeong Yun

JOBS:

Please click here for Standigm job opportunities.

2 articles with Standigm